Phlow

Phlow is proud to drive change through a modern medicine movement. At #SummitONE2025, our CEO, Eric Edwards, MD, PhD, joined leaders pushing for a more resilient, reliable pharmaceutical future. #ModernMedicine #EndDrugShortages #DomesticManufacturing #SupplyChainResilience

Phlow., a U.S.-based #CDMO, and Antheia, Inc., a #pharmaceutical ingredient manufacturer, announced progress on a partnership to strengthen domestic drug supply chains by producing key starting materials (#KSMs) in the United States. The collaboration, established in 2024, focuses on using Antheia’s #biosynthesis platform to manufacture KSMs that support Phlow’s pipeline of active pharmaceutical ingredients (#APIs). According to the companies, the initiative aims to reduce dependence on global suppliers for essential medicine components and mitigate risks associated with public health emergencies and international supply disruptions. Read more at: https://lnkd.in/gVPa7sq7 #biomanufacturing #pharmamanufacturing #pharmaceuticalmanufacturing #pharmaceuticalsupplychain #supplychain #medicine #lifescience #contractmanufacturing #flowchemistry #healthcare

#ICYMI -> #BIOontheAmericanRoad's recent stop in Virginia fostered—and captured—inspiring conversation between our incredible state partners, including John Newby, J.D., CAE, CEO of Virginia Bio; Chris Rogers, Chief Commercial Officer of Phlow; and Amy Yarcich, Executive Director of Rx Partnership. Read more: https://lnkd.in/ecJiebey

We sat down with Antheia and Phlow's Chief Scientific Officers for a deeper dive into the importance of this partnership and how our companies’ technologies complement each other, enabling us to go further together. Hear from Antheia CSO and co-founder, Dr. Kristy Hawkins and Phlow CSO, Dr. Andrew J. Carpenter, Ph.D. about the innovative manufacturing solutions that will transform our domestic pharmaceutical supply chains: https://bit.ly/4ob2rz7 #Antheia #Phlow #PharmaSupplyChains #Biomanufacturing #FlowChemistry

We’re proud to announce our ongoing partnership with Phlow to bolster efforts to onshore critical pharmaceutical supply chains to the U.S. Antheia and Phlow share a vision for a future of pharma that leverages advanced manufacturing technologies to enable efficient, agile, and domestic sources of essential medicines. Bringing together Antheia and Phlow's respective expertise in biomanufacturing and flow chemistry will enable a new era of resilient pharmaceutical manufacturing in America. Read more: https://bit.ly/4lJy9Sm #Antheia #Phlow #PharmaSupplyChains #Biomanufacturing #FlowChemistry

Phlow is proud to partner with Antheia, Inc. to accelerate the onshoring of essential medicine ingredient production and strengthen domestic pharmaceutical supply chains through advanced manufacturing technologies. Together, we are addressing one of the most pressing challenges in healthcare: the reliance on global sources for key starting materials and active pharmaceutical ingredients. By combining Phlow’s next-generation flow chemistry capabilities with Antheia, Inc.’s cutting-edge biosynthesis platform, we are enabling a secure, scalable, and sustainable solution for producing essential medicines right here in the United States. As Phlow's CEO, Eric Edwards, MD, PhD, said, “By working together to develop a U.S.-based, sustainable alternative for key starting materials derived from unpredictable, legacy sources, we are not only protecting American patients, but we’re also advancing our shared mission to strengthen national health security.” As we transform how and where critical medicines are made, we remain focused on delivering quality ingredients, greater stability, and a more prepared future for all Americans. This partnership is more than innovation; it is a strategic investment in national health security and public health resilience. We are building a stronger, more secure future, where essential medicines are made in America, for America. Read the full press release: https://lnkd.in/eTHrVPsy

Phlow is proud to join Angels for Change for SummitONE 2025 in Irving, Texas. This Thursday, our CEO and Chairman, Eric Edwards, MD, PhD, will speak on a panel addressing the importance of strengthening domestic pharmaceutical manufacturing and enhancing supply chain resilience. SummitONE brings together leaders across healthcare, government, and industry to collaborate on solutions to drug shortages. We’re honored to contribute to this important dialogue. #SummitONE2025 #SupplyChainResilience #Onshoring #DrugShortages #Phlow #EssentialMedicines

Phlow is hiring a Laboratory Assistant to support daily operations in our R&D and analytical labs, located in Richmond and Petersburg, Virginia. This is a full-time role that requires rotating between our Petersburg and Richmond locations throughout the week. The responsibilities of this role include ensuring safety and cleanliness, managing inventory and procurement of supplies, conducting equipment maintenance and calibration, and collaborating with scientists to achieve business objectives and timelines. We value a commitment to the highest standards of safety, integrity, transparency, and ethics in all aspects of work. If you or someone you know would be a great fit for this role, tag them in the comments below! Apply now: https://lnkd.in/e85cFHvq #Hiring #LabAssistant #PharmaJobs #LifeSciences #STEM

The new funding helps Phlow accelerate its mission to help make ingredients for medicines either considered in short supply or vulnerable because they come from other countries.

Phlow Corp., a U.S.-based contract development and manufacturing organization (#CDMO), announced it has raised $37 million in funding to support expansion of its development, manufacturing, and digital infrastructure. The company said the investment will be used to grow its #cGMP #manufacturing capabilities, scale advanced #pharmaceutical technologies, and strengthen domestic production of key starting materials (#KSMs) and active pharmaceutical ingredients (#APIs). Read more at: https://lnkd.in/gXYrBE7j #pharmamanufacturing #pauto #batchprocessing #continuousprocessing image credit: Shutterstock